Aleafia Health Shares Trading Higher On Hitting Positive Adjusted EBITDA In Q2 2023

Aleafia Health Inc. ALEAF AH Q2 2023 net revenue was CA$10.6 million ($7.9 million), a 10.4% increase compared to CA$9.6 million in the prior year.

Q2 2023 Financial Highlights

• Adjusted EBITDA was CA$83,000, compared to a loss of CA$8.9 million in Q2 2022.

• Gross profit was CA$15.6 million compared to a loss of CA$490,000 in Q2 2022.

• Net profit and comprehensive profit was CA$7 million, compared to a loss of CA$80.3 million in Q2 2022.

“We have worked diligently over the past 12 months to achieve this major milestone, and to be among the first publicly traded Canadian Licensed Producers to reach adjusted EBITDA profitability is an enormous accomplishment,” stated Tricia Symmes, CEO.

“It is the result of a relentlessly profit-focused management team putting into place the discipline and high-growth mindset instrumental in achieving this meaningful and substantial objective. The fact that this occurred during a period of market volatility with the OCS cybersecurity attack, the BC lockout and our whole flower supply constraints all impacting adult-use sales, is an even stronger testament to the power of our growing brands, led by Divvy,” continued Symmes.

Cost Savings

In Q3 FY2023, the company is enacting further cost savings initiatives with the wind down of its Grimsby greenhouse, representing an annualized net savings of approximately CA$4.1 million. The company will commence the process of winding down operations, effective November 2022, impacting 41 employees.

Price Action

Aleafia Health shares were trading 8.67% higher at $0.0619 per share at the time of writing Wednesday morning.

Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.

Photo by Esteban Lopez on Unsplash

Related News

Aleafia Health Q1 2023 Revenue Grows 41% YoY, What About Profit?

Aleafia Health Hits Record $43.1M Net Revenue In 2022 15-Month Fiscal Year, Closes Debenture Amendment Transaction

Aleafia Health Reaffirms Revenue Guidance, Implements $6.7 Million In Annualized Cost Savings